Clinical Trial Update: Safety and Efficacy Study of Regulatory T Cells in Treating Autoimmune Hepatitis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating regulatory T cell therapy for autoimmune hepatitis; status and results are not specified in the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Hepatitis

Drugs mentioned

• Regulatory T Cells Therapy (regulatory T cells)

Snippet

Sponsor: Nanjing Medical University | Conditions: Autoimmune Diseases | Phase 1, Phase 2 | Status: UNKNOWN